NEURONETICS INC (STIM) Stock News

USA - NASDAQ:STIM - US64131A1051 - Common Stock

2.76 USD

-0.03 (-1.08%)

Last: 10/13/2025, 5:27:05 PM

2.8198 USD

+0.06 (+2.17%)

After Hours: 10/13/2025, 5:27:05 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

STIM Latest News, Press Relases and Analysis

All

Press Releases

7 days ago - By: Benzinga - Mentions: SNWV ONMD ORMP TXMD ...

12 Health Care Stocks Moving In Monday's After-Market Session

a month ago - By: Neuronetics

New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)

a month ago - By: Neuronetics

New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)

2 months ago - By: Neuronetics

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

2 months ago - By: Benzinga - Mentions: AFG CXDO YUM PACK ...

Earnings Scheduled For August 5, 2025

2 months ago - By: Zacks Investment Research - Mentions: TNDM

Neuronetics (STIM) Reports Q2 Loss, Tops Revenue Estimates

2 months ago - By: Neuronetics

Neuronetics Reports Second Quarter 2025 Financial and Operating Results

2 months ago - By: Neuronetics

Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference

3 months ago - By: Neuronetics

NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents

3 months ago - By: Neuronetics

NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents

3 months ago - By: Neuronetics

Neuronetics to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call

3 months ago - By: Neuronetics

Neuronetics Appoints New Chief Financial Officer

3 months ago - By: Yahoo Finance

Neuronetics Showcases NeuroStar TMS Data at Clinical TMS Meeting

4 months ago - By: Neuronetics

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

4 months ago - By: Neuronetics

Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’s Personalized Care Trial Program

4 months ago - By: Neuronetics

Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’s Personalized Care Trial Program

4 months ago - By: Neuronetics

Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes

5 months ago - By: Neuronetics

Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month

5 months ago - By: Neuronetics

Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month

5 months ago - By: Zacks Investment Research - Mentions: GMED

Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates

5 months ago - By: Neuronetics

Neuronetics Reports First Quarter 2025 Financial and Operating Results

5 months ago - By: Neuronetics

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

6 months ago - By: Yahoo Finance - Mentions: DHI CMG

Why Neuronetics, Inc. (STIM) is Surging in 2025

6 months ago - By: Neuronetics

Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call

7 months ago - By: Neuronetics

Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression

7 months ago - By: Neuronetics

Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression

7 months ago - By: Neuronetics

Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results

7 months ago - By: Neuronetics

Neuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

7 months ago - By: Neuronetics

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

8 months ago - By: Neuronetics

Neuronetics to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call

8 months ago - By: Neuronetics

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

8 months ago - By: Neuronetics

Neuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common Stock

8 months ago - By: Neuronetics

Neuronetics Announces Launch of Underwritten Public Offering of Common Stock